1.
|
R StuppWP MasonMJ van den BentM WellerB
FisherMJ TaphoornK BelangerRadiotherapy plus concomitant and
adjuvant temozolomide for glioblastomaN Engl J
Med352987996200510.1056/NEJMoa04333015758009
|
2.
|
D FultonR UrtasunP ForsythPhase II study
of prolonged oral therapy with etoposide (VP16) for patients with
recurrent malignant gliomaJ
Neurooncol27149155199610.1007/BF001774788699237
|
3.
|
HS FriedmanWP PetrosAH FriedmanLJ SchaafT
KerbyJ LawyerM ParryIrinotecan therapy in adults with recurrent or
progressive malignant gliomaJ Clin Oncol1715161525199910334539
|
4.
|
WK YungRE AlbrightJ OlsonR FredericksK
FinkMD PradosM BradaA phase II study of temozolomide vs.
procarbazine in patients with glioblastoma multiforme at first
relapseBr J Cancer83588593200010.1054/bjoc.2000.131610944597
|
5.
|
RE WarnickMD PradosEE MackKL ChandlerF
DozJE RabbittMK MalecA phase II study of intravenous carboplatin
for the treatment of recurrent gliomasJ
Neurooncol196974199410.1007/BF010510507815106
|
6.
|
Y WangD FeiM VanderlaanA SongBiological
activity of bevacizumab, a humanized anti-VEGF antibody in
vitroAngiogenesis7335345200410.1007/s10456-004-8272-215886877
|
7.
|
V Stark-VanceBevacizumab and CPT-11 in the
treatment of relapsed malignant glioma. Abstracts from the World
Federation of Neuro-Oncology Second Quadrennial Meeting and the
Sixth Meeting of the European Association for
Neuro-OncologyNeuro-Oncol7abstract 3422005
|
8.
|
JJ VredenburghA DesjardinsJE Herndon IIJ
MarcelloDA ReardonJA QuinnJN RichBevacizumab plus irinotecan in
recurrent glioblastoma multiformeJ Clin
Oncol2547224729200710.1200/JCO.2007.12.244017947719
|
9.
|
JJ VredenburghA DesjardinsJE Herndon IIJM
DowellDA ReardonJA QuinnJN RichPhase II trial of bevacizumab and
irinotecan in recurrent malignant gliomaClin Cancer
Res1312531259200710.1158/1078-0432.CCR-06-230917317837
|
10.
|
HS FriedmanMD PradosPY WenT MikkelsenD
SchiffLE AbreyWK YungBevacizumab alone and in combination with
irinotecan in recurrent glioblastomaJ Clin
Oncol2747334740200910.1200/JCO.2008.19.872119720927
|
11.
|
TN KreislL KimK MooreP DuicC RoyceI
StroudN GarrenPhase II trial of single-agent bevacizumab followed
by bevacizumab plus irinotecan at tumor progression in recurrent
glioblastomaJ Clin
Oncol27740745200910.1200/JCO.2008.16.305519114704
|
12.
|
DA ReardonA DesjardinsJJ VredenburghS
GururanganJH SampsonS SathornsumeteeRE McLendonMetronomic
chemotherapy with daily, oral etoposide plus bevacizumab for
recurrent malignant glioma: a phase II studyBr J
Cancer10119861994200910.1038/sj.bjc.660541219920819
|
13.
|
S SathornsumeteeA DesjardinsJJ
VredenburghRE McLendonJ MarcelloJE HerndonA MathePhase II trial of
bevacizumab and erlotinib in patients with recurrent malignant
gliomaNeuro Oncol1213001310201020716591
|
14.
|
A DesjardinsDA ReardonA CoanJ MarcelloJE
Herndon IIL BaileyKB PetersBevacizumab and daily temozolomide for
recurrent
glioblastomaCancer11813021312201210.1002/cncr.2638121792866
|
15.
|
DA ReardonA DesjardinsKB PetersS
GururanganJH SampsonRE McLendonJE Herndon IIPhase II study of
carboplatin, irinotecan and bevacizumab for bevacizumab naïve,
recurrent glioblastomaJ Neurooncol107155164201221986722
|
16.
|
AB FrancesconiS DupreM MatosD MartinBG
HughesDK WyldJD LickliterCarboplatin and etoposide combined with
bevacizumab for the treatment of recurrent glioblastoma multiformeJ
Clin Neurosci17970974201010.1016/j.jocn.2009.12.00920541421
|
17.
|
EM ThompsonE DosaDF KraemerEA
NeuweltTreatment with bevacizumab plus carboplatin for recurrent
malignant
gliomaNeurosurgery678793201010.1227/01.NEU.0000370918.51053.BC20559095
|
18.
|
WK YungL MechtlerMJ GleasonIntravenous
carboplatin for recurrent malignant glioma: a phase II studyJ Clin
Oncol986086419911849986
|
19.
|
B JeremicD GrujicicS JevremovicB
StanisavljevicL MilojevicL DjuricL MijatovicCarboplatin and
etoposide chemotherapy regimen for recurrent malignant glioma: a
phase II studyJ Clin Oncol101074107719921318951
|
20.
|
RK JainNormalization of tumor vasculature:
an emerging concept in antiangiogenic
therapyScience3075862200510.1126/science.110481915637262
|
21.
|
RK JainAntiangiogenic therapy for cancer:
current and emerging conceptsOncology (Williston
Park)19716200515934498
|
22.
|
AD NordenGS YoungK SetayeshA MuzikanskyR
KlufasGL RossAS CiampaBevacizumab for recurrent malignant gliomas:
efficacy, toxicity, and patterns of
recurrenceNeurology70779787200810.1212/01.wnl.0000304121.57857.3818316689
|